It might be difficult for an FDA advisory committee to refrain from comparing and contrasting Janssen's vaccine with two others. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
